Navigation Links
Neuralstem Secures $8 Million In Debt Financing From Hercules
Date:3/25/2013

received approval to commence a Phase I safety trial in chronic spinal cord injury in January 2013.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  The company is in a Phase Ib safety trial evaluating NSI-189, its first neurogenic small molecule compound, for the treatment of major depressive disorder (MDD). Additional indications could include chronic traumatic encephalopathy (CTE), Alzheimer's disease, and post-traumatic stress disorder (PTSD).

For more information, please visit www.neuralstem.com or connect with us on Twitter, Facebook and LinkedIn

About Hercules Technology Growth Capital, Inc.

Hercules Technology Growth Capital, Inc. (NYSE: HTGC) ("Hercules") (www.HTGC.com) is the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science and cleantech industries at all stages of development. Since inception (December 2003), Hercules has committed more than $3.4 billion to over 220 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing.

Cautionary Statement Regarding Forward Looking Information         
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
2. Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013
3. Neuralstem to Raise $7.0 Million in Registered Direct Offering
4. Neuralstem Announces Proposed Public Offering
5. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
6. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
7. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
8. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
9. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
10. Neuralstem Updates ALS Stem Cell Trial Progress
11. Total Artificial Heart Manufacturer SynCardia Secures $19M Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 Bronstein, Gewirtz & Grossman, ... of the securities of PDL BioPharma, Inc. ("PDL BioPharma" ... Such investors are advised to contact Peretz Bronstein ... at info@bgandg.com or 212-697-6484. ... of its executives violated federal securities laws. ...
(Date:9/17/2014)... September 17, 2014 ... has shown positive data in a Phase 2a proof ... , Glenmark Pharmaceuticals today announced ... 1 (TRPA1) antagonist, GRC 17536 has shown positive data ... proof of concept study conducted on 138 patients in ...
(Date:9/17/2014)... 2014   MedeAnalytics today unveils Revenue ... complete visibility to a provider,s "mid-cycle" to optimize ... landscape. Powered by the industry,s leading big data ... point between patient access and the business office ... improve revenue capture, minimize audit risk and prepare ...
Breaking Medicine Technology:Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3
... New study finds patients who opt for surgery have decreased pain, ... with the spine disease called degenerative spondylolisthesis * ... pain over time compared to those who do not have surgery, ... The Journal of Bone and Joint Surgery ...
... GAITHERSBURG, Md., June 1 Overall survival data in ... GenVec,s ongoing Phase III Pancreatic Cancer Clinical Trial with ... Society of Clinical Oncology Annual Meeting in Orlando, FL. ... ) , , The poster ...
Cached Medicine Technology:Back to Normal: Surgery Improves Outcomes for Spine Patients 2Back to Normal: Surgery Improves Outcomes for Spine Patients 3Back to Normal: Surgery Improves Outcomes for Spine Patients 4TNFerade(TM) Phase III Data Presented at ASCO 2TNFerade(TM) Phase III Data Presented at ASCO 3
(Date:9/17/2014)... Steven Reinberg HealthDay Reporter ... uncovered a key factor to explain why antibiotic-resistant bacteria can ... DNA called plasmids appear to be the culprit. They can ... and some carry a gene that makes bacteria drug-resistant, a ... carry an antibiotic-resistant gene to a class of antibiotic called ...
(Date:9/17/2014)... able to reduce the need for invasive biopsies in ... lupus. , In a new study, researchers developed a ... kidney inflammation to interstitial fibrosis, scarring in ... biopsy is the only existing way to reach a ... The model could also be used to monitor the ...
(Date:9/17/2014)... September 17, 2014 Today, Blue ... million in third-quarter grantmaking. This body of grants aims ... spreading innovations in care delivery, as well as to ... uninsured. Grants will also strengthen the capacity of both ... responsive and create new entry points for domestic violence ...
(Date:9/17/2014)... 2014 In a country where 77% ... a regular basis, how can Americans find healthy and ... Hyland’s Stress Challenge , a 5-day interactive journey to ... life. From September 29th – October 3rd, the ... relating to specific topics that promote natural solutions for ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. ... confirmed cases of Enterovirus D68, the severe respiratory illnesses ... officials report. Alabama, Colorado, Illinois, Indiana, Iowa, Kansas, ... have 130 laboratory-confirmed cases of Enterovirus D68, according to ... The virus, part of the family of viruses that ...
Breaking Medicine News(10 mins):Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 3Health News:Math model designed to replace invasive kidney biopsy for lupus patients 2Health News:Blue Shield of California Foundation Awards $5 Million in Third-Quarter Grants 2Health News:Stress Less with the Hyland's 5-Day Stress Challenge 2Health News:12 States Now Reporting Severe Respiratory Illness That Targets Kids 2Health News:12 States Now Reporting Severe Respiratory Illness That Targets Kids 3
... , WEDNESDAY, Feb. 9 (HealthDay News) -- The number ... attempts swings sharply depending on what month it is, a ... for men aged 50 and older, while there was little ... the report from the Substance Abuse and Mental Health Services ...
... many patients realise that diabetes can affect their kidneys is ... multi-cultural study in the March issue of the Journal ... to 48 patients with diabetes attending specialist renal services in ... risks posed by the disease was very low. ...
... Researchers from the Hospital Virgen de las Nieves of ... frequent mutations in the gene KCNH2 in patients with long ... cardiac ionic channels that approximately affects one in every 2,500 ... trigger sudden death. This condition usually affects children and adolescents, ...
... Sciences Discovery Fund (LSDF) today announced nearly $600,000 in ... the diagnosis and management of major health conditions. ... producing novel tests to diagnose or monitor disease. Jane ... a Washington-based company, will adapt a novel air sampling ...
... HealthDay Reporter , TUESDAY, Feb. 8 (HealthDay News) -- Men ... bearing children with congenital problems such as a cleft palate compared ... research. But the overall risk was low, researchers from Sweden ... of the National Cancer Institute . And the findings ...
... at the University at Buffalo have devised two new ... important molecules from losing their shape and degrading in ... the development of peptide-based drugs against diseases including cancer. ... than existing techniques, one of which employs an expensive ...
Cached Medicine News:Health News:Males' Drug-Related Suicide Attempts Vary by Month 2Health News:Experts call for greater awareness of the links between diabetes and kidney disease 2Health News:Experts call for greater awareness of the links between diabetes and kidney disease 3Health News:Researchers identify the genotype of disorders causing cardiac sudden death syndrome 2Health News:Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies 2Health News:Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies 3Health News:Birth Defect Risk Slightly Higher for Kids of Male Cancer Survivors 2Health News:Birth Defect Risk Slightly Higher for Kids of Male Cancer Survivors 3Health News:New techniques for stapling peptides could spur development of drugs for cancer 2
... Pulse Oximeter monitors SpO2, pulse ... is designed to provide fast, ... The device rejects spontaneous motion ... operator of excess artifacts and ...
... Radical can operate in two additional ... be removed, creating a fully featured handheld ... also be used to upgrade existing equipment ... additinal hardware or software upgrades to improve ...
Halogen-free immersion oil based on ester oil....
Immersion Oil, 150 cs...
Medicine Products: